Portal de investigación
High-grade/large B-cell lymphoma-11q has a very good prognosis in children and young people without a predisposition
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Ronceray, L
- Huibers, MHW
- Reutter, K
- Abla, O
- Balagué, O
- Csóka, M
- Gilad, G
- Hagleitner, MM
- Hori, D
- Hjalgrim, LL
- Jazbec, J
- Klapper, W
- Nakazawa, A
- Verdú-Amoros, J
- Von Mersi, H
- Wössmann, W
- Xavier, AC
- Burkhardt, B
- Salaverria, I
- Attarbaschi, A
Grupos
Abstract
Abstract: High-grade B-cell lymphoma with 11q aberration (HGBCL-11q) is a rare pediatric non-Hodgkin lymphoma. This study assessed outcome in 90 children with HGBCL-11q. With survival rates =95%, patients with HGBCL-11q and no predisposition are candidates for deescalated therapy in future prospective trials. © 2026 American Society of Hematology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Datos de la publicación
- ISSN/ISSNe:
- 0006-4971, 1528-0020
- Tipo:
- Letter
- Páginas:
- 209-214
- PubMed:
- 41160801
- Enlace a otro recurso:
- www.scopus.com
- Factor de Impacto:
- 4,834 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
BLOOD ELSEVIER
Citas Recibidas en Web of Science: 4
Documentos
- No hay documentos
Filiaciones
Keywords
- adolescent; cancer grading; child; chromosome 11; diagnosis; diffuse large B cell lymphoma; female; genetic predisposition; genetics; human; infant; male; mortality; pathology; preschool child; prognosis; Adolescent; Child; Child, Preschool; Chromosomes, Human, Pair 11; Female; Genetic Predisposition to Disease; Humans; Infant; Lymphoma, Large B-Cell, Diffuse; Male; Neoplasm Grading; Prognosis
Campos de Estudio
Cita
Ronceray L,Huibers MHW,Reutter K,Abla O,Andrés M,Balagué O,Csóka M,Gilad G,Hagleitner MM,Hori D,Hjalgrim LL,Jazbec J,Klapper W,Nakazawa A,Verdú J,Von H,Wössmann W,Xavier AC,Burkhardt B,Salaverria I,Attarbaschi A. High-grade/large B-cell lymphoma-11q has a very good prognosis in children and young people without a predisposition. Blood. 2026. 147(2):p. 209-214. IF:23,900. (1).